Jochen Schmitz - Siemens Healthineers CFO, Member of the Managing Board

SEMHF Stock  USD 53.00  1.37  2.65%   

CFO

Dr. Jochen Schmitz, Ph.D., was Chief Financial Officer and Member of the Managing Board of Siemens Healthineers AG since December 2017. He joined Siemens in 1996 after the completion of his studies in Business Administration and Economics at the University of Augsburg. He also holds a Ph.D. in the same field. After various positions with increasing responsibility in Corporationrationrate Finance in Germany he joined Siemens Healthcare in 2004, holding several executive finance positions in the Healthcare business in the United States and Germany. Among others he was Chief Financial Officer of the Diagnostics Division in the United States and Chief Financial Officer of the Imaging Therapy Systems Division in Germany until 2011. Afterwards, he had served for six years as Corporationrationrate Vice President Controller of Siemens AG until he finally came back to Siemens Healthineers. since 2017.
Age 57
Tenure 7 years
Phone49 9131 84 3385
Webhttps://www.siemens-healthineers.com

Siemens Healthineers Management Efficiency

The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.
Siemens Healthineers AG has accumulated 15 M in total debt with debt to equity ratio (D/E) of 0.85, which is about average as compared to similar companies. Siemens Healthineers has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Siemens Healthineers until it has trouble settling it off, either with new capital or with free cash flow. So, Siemens Healthineers' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Siemens Healthineers sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Siemens to invest in growth at high rates of return. When we think about Siemens Healthineers' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

CFO Age

Douglas RiceOrthofix Medical
58
Todd CPACONMED
55
Diron SmithInteger Holdings Corp
50
Lance CPAArtivion
52
Stephen GriffinAnika Therapeutics
38
Chadi ChahineParagon 28
51
Peter MarianiAxogen Inc
60
Alison BauerleinSight Sciences
43
Roderick MacLeodNevro Corp
57
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. Siemens Healthineers is traded on OTC Exchange in the United States. Siemens Healthineers AG [SEMHF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Siemens Healthineers Leadership Team

Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andre Hartung, Head Imaging
Christian Klaussner, Ex Fin
Carsten Bertram, Head Therapies
Bernhard Montag, President of the Management Board, CEO
Christopher Toth, Head Varian
Darleen Caron, Labor Officer
Marc Koebernick, Head Relations
Michel DVM, Pres Therapies
Jochen Schmitz, CFO, Member of the Managing Board
Elisabeth Staudinger, Member Board

Siemens Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Siemens Pink Sheet

Siemens Healthineers financial ratios help investors to determine whether Siemens Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Siemens with respect to the benefits of owning Siemens Healthineers security.